Prema Cognition is a digital healthtech company focused on earlier detection of dementia. It is the company behind PREMAZ, a digital cognitive assessment created in collaboration with the University of Cambridge Memory Lab. PREMAZ is designed to identify subtle changes in cognitive decline long before symptoms appear. By translating advanced neuroscience into a clinician-ready digital tool, Prema Cognition is enabling earlier intervention and supporting research into brain health. The platform is already in use across clinics and research settings in the UK and US. Prema Cognition was co-founded by medical doctor Dr. Julia Cooney, a Forbes 30 Under 30 honoree and Cameron Kirkpatrick.
Prema Cognition
- Health
- Cambridge, United Kingdom
- £550k
- premaz.org
- Update Information
More venture news
- 30 Jun 2026
SaltroadSaltroad raises £1.5m in funding led by Techstart Ventures to build an AI-enabled speech and language therapy workforce
EquityHealth - 30 Jun 2026

NeuronosticsNeuronostics raises £3m in funding led by Empirical Ventures and The FSE Group for platform that diagnoses epilepsy from brain activity recordings
EquityHealth - 24 Jun 2026

NeubondNeubond raises a £1.5m seed round led by Waseda University Ventures for sustainable stroke rehabilitation platform
SeedHealth
